Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a hormone shield kidneys during liver transplant?

NCT ID NCT06344442

First seen Feb 05, 2026 · Last updated Apr 29, 2026 · Updated 10 times

Summary

This study tests whether giving a low dose of the hormone vasopressin during liver transplant surgery can prevent acute kidney injury, a common complication. About 304 adults scheduled for a liver transplant will receive either vasopressin or standard treatment. The goal is to see if vasopressin better protects kidney function after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY POST LIVER TRANSPLANTATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • URC Lariboisière-Fernand Widal-saint Louis

    RECRUITING

    Paris, 75010, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.